Actoplus Met Xr is owned by Takeda Pharms Usa.
Actoplus Met Xr contains Metformin Hydrochloride; Pioglitazone Hydrochloride.
Actoplus Met Xr has a total of 5 drug patents out of which 0 drug patents have expired.
Actoplus Met Xr was authorised for market use on 12 May, 2009.
Actoplus Met Xr is available in tablet, extended release;oral dosage forms.
The generics of Actoplus Met Xr are possible to be released after 31 July, 2026.
Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8668931 | TAKEDA PHARMS USA | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
Sep, 2023
(3 months from now) | |
US8470368 | TAKEDA PHARMS USA | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
Sep, 2023
(3 months from now) | |
US9060941 | TAKEDA PHARMS USA | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
Sep, 2023
(3 months from now) | |
US7785627 | TAKEDA PHARMS USA | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
Jul, 2026
(3 years from now) | |
US7959946 | TAKEDA PHARMS USA | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
Jul, 2026
(3 years from now) |
Drugs and Companies using METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE ingredient
Market Authorisation Date: 12 May, 2009
Treatment: NA
Dosage: TABLET, EXTENDED RELEASE;ORAL
17
United States
7
Korea, Republic of
6
Japan
5
China
4
Australia
4
European Union
3
Canada
3
New Zealand
3
Spain
3
Hong Kong
2
Brazil
2
Taiwan
1
EA
1
Israel
1
Peru
1
Malaysia
1
Costa Rica
1
Singapore
1
Ukraine
1
Morocco
1
Norway
1
Mexico
1
Georgia
1
Argentina
1
South Africa
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic